The co-existence of myasthenia gravis in patients with myositis: A case series

Julie Paik, Andrea Markl Corse, Andrew L. Mammen

Research output: Contribution to journalArticle

Abstract

Objective: Myositis and myasthenia gravis (MG) are both autoimmune disorders presenting with muscle weakness. Rarely, they occur simultaneously in the same patient. Since the management of myasthenia gravis differs from that of myositis, it is important to recognize when patients have both diseases. We reviewed the cases of 6 patients with both myositis and MG to identify clinical features that suggest the possibility of co-existing MG in myositis patients. Methods: We identified 6 patients with dermatomyositis or polymyositis and MG. We reviewed their medical records to assess their clinical presentations, laboratory findings, and electrophysiological features. Results: All 6 patients had definite dermatomyositis or polymyositis by the criteria of Bohan and Peter as well as electrophysiologic and/or serologic confirmation of MG. Among overlap patients, 5/6 (83%) had bulbar weakness, 2/6 (33%) had ptosis, and 1/6 (17%) had diplopia. Fatigable weakness was noted by 5/6 (83%) patients. Treatment with pyridostigmine improved symptoms in 5/6 (83%) patients. High-dose steroids were associated with worsening weakness in 2/6 (33%) patients. Conclusions: Prominent bulbar symptoms, ptosis, diplopia, and fatigable weakness should suggest the possibility of MG in patients with myositis. A suspicion of MG may be confirmed through appropriate electrophysiologic and laboratory testing. In those with myositis-MG overlap, high-dose steroids may exacerbate symptoms and pyridostigmine may play an important therapeutic role.

Original languageEnglish (US)
Pages (from-to)792-796
Number of pages5
JournalSeminars in Arthritis and Rheumatism
Volume43
Issue number6
DOIs
StatePublished - 2014

Fingerprint

Myositis
Myasthenia Gravis
Pyridostigmine Bromide
Dermatomyositis
Diplopia
Steroids
Muscle Weakness
Medical Records

Keywords

  • Dermatomyositis
  • Myasthenia gravis
  • Myositis
  • Polymyositis

ASJC Scopus subject areas

  • Rheumatology
  • Anesthesiology and Pain Medicine
  • Medicine(all)

Cite this

The co-existence of myasthenia gravis in patients with myositis : A case series. / Paik, Julie; Corse, Andrea Markl; Mammen, Andrew L.

In: Seminars in Arthritis and Rheumatism, Vol. 43, No. 6, 2014, p. 792-796.

Research output: Contribution to journalArticle

@article{0fd6fc3c885a45f294124d9057e1aecd,
title = "The co-existence of myasthenia gravis in patients with myositis: A case series",
abstract = "Objective: Myositis and myasthenia gravis (MG) are both autoimmune disorders presenting with muscle weakness. Rarely, they occur simultaneously in the same patient. Since the management of myasthenia gravis differs from that of myositis, it is important to recognize when patients have both diseases. We reviewed the cases of 6 patients with both myositis and MG to identify clinical features that suggest the possibility of co-existing MG in myositis patients. Methods: We identified 6 patients with dermatomyositis or polymyositis and MG. We reviewed their medical records to assess their clinical presentations, laboratory findings, and electrophysiological features. Results: All 6 patients had definite dermatomyositis or polymyositis by the criteria of Bohan and Peter as well as electrophysiologic and/or serologic confirmation of MG. Among overlap patients, 5/6 (83{\%}) had bulbar weakness, 2/6 (33{\%}) had ptosis, and 1/6 (17{\%}) had diplopia. Fatigable weakness was noted by 5/6 (83{\%}) patients. Treatment with pyridostigmine improved symptoms in 5/6 (83{\%}) patients. High-dose steroids were associated with worsening weakness in 2/6 (33{\%}) patients. Conclusions: Prominent bulbar symptoms, ptosis, diplopia, and fatigable weakness should suggest the possibility of MG in patients with myositis. A suspicion of MG may be confirmed through appropriate electrophysiologic and laboratory testing. In those with myositis-MG overlap, high-dose steroids may exacerbate symptoms and pyridostigmine may play an important therapeutic role.",
keywords = "Dermatomyositis, Myasthenia gravis, Myositis, Polymyositis",
author = "Julie Paik and Corse, {Andrea Markl} and Mammen, {Andrew L.}",
year = "2014",
doi = "10.1016/j.semarthrit.2013.12.005",
language = "English (US)",
volume = "43",
pages = "792--796",
journal = "Seminars in Arthritis and Rheumatism",
issn = "0049-0172",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - The co-existence of myasthenia gravis in patients with myositis

T2 - A case series

AU - Paik, Julie

AU - Corse, Andrea Markl

AU - Mammen, Andrew L.

PY - 2014

Y1 - 2014

N2 - Objective: Myositis and myasthenia gravis (MG) are both autoimmune disorders presenting with muscle weakness. Rarely, they occur simultaneously in the same patient. Since the management of myasthenia gravis differs from that of myositis, it is important to recognize when patients have both diseases. We reviewed the cases of 6 patients with both myositis and MG to identify clinical features that suggest the possibility of co-existing MG in myositis patients. Methods: We identified 6 patients with dermatomyositis or polymyositis and MG. We reviewed their medical records to assess their clinical presentations, laboratory findings, and electrophysiological features. Results: All 6 patients had definite dermatomyositis or polymyositis by the criteria of Bohan and Peter as well as electrophysiologic and/or serologic confirmation of MG. Among overlap patients, 5/6 (83%) had bulbar weakness, 2/6 (33%) had ptosis, and 1/6 (17%) had diplopia. Fatigable weakness was noted by 5/6 (83%) patients. Treatment with pyridostigmine improved symptoms in 5/6 (83%) patients. High-dose steroids were associated with worsening weakness in 2/6 (33%) patients. Conclusions: Prominent bulbar symptoms, ptosis, diplopia, and fatigable weakness should suggest the possibility of MG in patients with myositis. A suspicion of MG may be confirmed through appropriate electrophysiologic and laboratory testing. In those with myositis-MG overlap, high-dose steroids may exacerbate symptoms and pyridostigmine may play an important therapeutic role.

AB - Objective: Myositis and myasthenia gravis (MG) are both autoimmune disorders presenting with muscle weakness. Rarely, they occur simultaneously in the same patient. Since the management of myasthenia gravis differs from that of myositis, it is important to recognize when patients have both diseases. We reviewed the cases of 6 patients with both myositis and MG to identify clinical features that suggest the possibility of co-existing MG in myositis patients. Methods: We identified 6 patients with dermatomyositis or polymyositis and MG. We reviewed their medical records to assess their clinical presentations, laboratory findings, and electrophysiological features. Results: All 6 patients had definite dermatomyositis or polymyositis by the criteria of Bohan and Peter as well as electrophysiologic and/or serologic confirmation of MG. Among overlap patients, 5/6 (83%) had bulbar weakness, 2/6 (33%) had ptosis, and 1/6 (17%) had diplopia. Fatigable weakness was noted by 5/6 (83%) patients. Treatment with pyridostigmine improved symptoms in 5/6 (83%) patients. High-dose steroids were associated with worsening weakness in 2/6 (33%) patients. Conclusions: Prominent bulbar symptoms, ptosis, diplopia, and fatigable weakness should suggest the possibility of MG in patients with myositis. A suspicion of MG may be confirmed through appropriate electrophysiologic and laboratory testing. In those with myositis-MG overlap, high-dose steroids may exacerbate symptoms and pyridostigmine may play an important therapeutic role.

KW - Dermatomyositis

KW - Myasthenia gravis

KW - Myositis

KW - Polymyositis

UR - http://www.scopus.com/inward/record.url?scp=84902544058&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902544058&partnerID=8YFLogxK

U2 - 10.1016/j.semarthrit.2013.12.005

DO - 10.1016/j.semarthrit.2013.12.005

M3 - Article

C2 - 24412588

AN - SCOPUS:84902544058

VL - 43

SP - 792

EP - 796

JO - Seminars in Arthritis and Rheumatism

JF - Seminars in Arthritis and Rheumatism

SN - 0049-0172

IS - 6

ER -